← Leaderboards
Tingting Hong
University Of California, San Francisco
$5,335,730
Attributed
$7,577,695
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,577,695 · 6
By mechanism
R01$6,252,056 · 3
R00$730,068 · 1
R21$419,375 · 1
K99$176,196 · 1
Top collaborators
- Robin Mark Shaw9 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Michael C Bressan$4,535,090
- Dylan A. McCreedy$2,138,668
- Thomas H Everett$4,458,908
- Kevin Yackle$6,517,625
- Henry F. Vanbrocklin$15,230,142
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacCardiac MyocytesHeartCalciumHeart FailureL-Type Calcium ChannelsVentricularMembraneUnited StatesEpidemicInnovationCellsSurfaceAmericanAffectImageUnited States National Institutes Of HealthHeart FunctionBiochemicalProteinsSyndromeRegulationFunctional DisorderImpairment
Grant awards (20)
Correcting Cardiac Microdomains Reverses Non-Ischemic Cardiomyopathy$616,000
R01 · FY2025 · HL
Correcting Cardiac Microdomains Reverses Non-Ischemic Cardiomyopathy$603,680
R01 · FY2024 · HL
Regulation of Cav1.2 Trafficking by GJA1-20k and cBIN1$550,133
R01 · FY2024 · HL
Correcting Cardiac Microdomains Reverses Non-Ischemic Cardiomyopathy$616,000
R01 · FY2023 · HL
Regulation of Cav1.2 Trafficking by GJA1-20k and cBIN1$561,360
R01 · FY2023 · HL
Regulation of Cav1.2 Trafficking by GJA1-20k and cBIN1$561,360
R01 · FY2022 · HL
Advancing cBIN1 Therapy to Large Preclinical Animals$228,750
R21 · FY2022 · AG
Regulation of Cav1.2 Trafficking by GJA1-20k and cBIN1$556,023
R01 · FY2021 · HL
Advancing cBIN1 Therapy to Large Preclinical Animals$190,625
R21 · FY2021 · AG
Regulation of Ion Channels at BIN1-induced T-tubule Microdomains$381,250
R01 · FY2020 · HL · contact PI
Regulation of Ion Channels at BIN1-induced T-tubule Microdomains$56,250
R01 · FY2020 · HL · contact PI
Regulation of Ion Channels at BIN1-induced T-tubule Microdomains$437,500
R01 · FY2019 · HL · contact PI
Regulation of Ion Channels at BIN1-induced T-tubule Microdomains$437,500
R01 · FY2018 · HL · contact PI
Regulation of Ion Channels at BIN1-induced T-tubule Microdomains$437,500
R01 · FY2017 · HL · contact PI
Regulation of Ion Channels at BIN1-induced T-tubule Microdomains$437,500
R01 · FY2016 · HL · contact PI
BIN1 is a mediator and marker of cardiac reserve in heart failure.$249,000
R00 · FY2015 · HL · contact PI
BIN1 is a mediator and marker of cardiac reserve in heart failure.$244,020
R00 · FY2014 · HL · contact PI
BIN1 is a mediator and marker of cardiac reserve in heart failure.$237,048
R00 · FY2013 · HL · contact PI
BIN1 is a mediator and marker of cardiac reserve in heart failure.$86,196
K99 · FY2013 · HL · contact PI
BIN1 is a mediator and marker of cardiac reserve in heart failure.$90,000
K99 · FY2012 · HL · contact PI